铁基磁性纳米载体在肿瘤治疗中的应用

doi:10.3969/j.issn.2097-0005.2021.05.003

betway必威登陆网址（betway.com ）学报 ›› 2021, Vol. 42 ›› Issue (5): 333-339.DOI: 10.3969/j.issn.2097-0005.2021.05.003

铁基磁性纳米载体在肿瘤治疗中的应用

牛盼红¹, 王岩¹, 刘营营¹, 张洁¹, 张书平^1,2, 刘思金³

betway必威登陆网址 (betway.com ) 1.生物医学科学学院;
2.医学科技创新中心,山东济南 250062;
3.中国科学院生态环境研究中心,环境化学与生态毒理学国家重点实验室,北京 100085

收稿日期:2021-03-15 出版日期:2021-05-25 发布日期:2021-08-31
通讯作者: 张书平,E-mail:spzhang@sdfmu.edu.cn。
作者简介:牛盼红,副教授,博士,研究方向:铁死亡驱动纳米治疗和炎症疾病靶向治疗。刘思金,中国科学院遗传与发育生物学研究所博士,美国麻省理工学院和美国哈佛大学医学院附属儿童医院博士后,研究员,国家杰出青年基金获得者,中科院百人计划入选者,万人计划入选者,国家973项目首席科学家。主持国家自然基金面上项目2项,中国科学院知识创新工程重要方向项目1项,中国科学院“百人计划”项目1项。研究方向:环境毒理与健康、纳米材料和颗粒物的安全性与转化毒理,已发表SCI学术论文150余篇。研究成果先后在国际著名期刊上发表,部分研究成果被Nature、Science Daily等学术期刊多次报道和评述。张书平,betway必威登陆网址特聘教授,泰山学者青年专家。主要研究铁代谢紊乱诱导的造血障碍、癌症等疾病的发生发展以及铁死亡介导的相关分子机制,并探索相应的纳米治疗;同时关注环境污染等外界风险因素对铁代谢和疾病进程的影响。近5年共发表相关SCI论文30余篇,包括以第一或通讯作者发表在Blood、Advanced Science、eLife、ACS Nano、Journal of Hazardous Materials等权威期刊上;参与专著编撰一部;主持和参与多项国家自然科学基金、国家973等项目。
基金资助:
国家自然科学资金(22076104);betway必威登陆网址 “科教融合人才引进”项目。

Application of iron-based magnetic nanocarriers in tumor therapy

Niu Panhong¹, Wang Yan¹, Liu Yingying¹, Zhang Jie¹, Zhang Shuping^1,2, Liu Sijin³

1. Academy of Medical Sciences;
2. Medical Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250062, China;
3. State Key Laboratory of Environmental Chemistry and Ecotoxicology Research Center for Eco-Environmental Sciences Chinese Academy of Sciences, Beijing 100085, China

Received:2021-03-15 Online:2021-05-25 Published:2021-08-31

摘要/Abstract

摘要： 纳米载药在肿瘤治疗中所取得的进展推动了纳米材料在生物医学方向的发展,其中,铁基磁性纳米材料因其良好的磁学、优异的生物兼容性以及表面易于功能化修饰等优势,作为纳米载体在肿瘤治疗中得到了广泛关注和快速发展。虽然目前对Fe₃O₄磁性纳米载体有了系统性的了解,但对作为纳米载体的铁基磁性纳米粒子的全面、系统认识仍有待加强。随着肿瘤纳米递药系统设计的快速发展,亟需对铁基磁性纳米载体的制备过程和作用机理进行系统性的梳理。此外,铁死亡作为一种新型细胞死亡方式,其在肿瘤等慢性疾病的发生发展过程中的作用正逐步被重视,而铁基磁性纳米粒子在肿瘤治疗应用中对铁死亡产生怎样的影响,仍有待阐明。本综述系统介绍了铁基磁性纳米载药平台的发展、种类和制备方法,并详细总结了铁基磁性纳米粒子在肿瘤诊疗一体化中的应用,包括磁场辅助靶向、磁共振成像、磁热治疗等方面,同时对其参与Fenton反应引发铁死亡的相关机理进行了阐述。

关键词: 纳米载药, 铁基磁性纳米载体, 肿瘤, 铁死亡

Abstract: Nano-drug delivery for tumor therapy has promoted the development of nanomaterials in the realm of biomedicine. Among them, iron-based magnetic nanomaterials have the advantages of good magnetism, excellent biocompatibility, and easy functional modification of the surface. As a nanocarrier, iron-based magnetic nanomaterials have received extensive attention and achieved rapid development in tumor therapy. Although there is a systematic understanding of Fe₃O₄ magnetic nanocarriers, the comprehensive and systematic understanding of iron-based magnetic nanoparticles carriers still needs to be strengthened. With the rapid development of tumor nano-drug delivery system design, it is urgent to systematically review the preparation process and mechanism of iron-based magnetic nanocarriers. In addition, ferroptosis, as a new type of cell death, receives much more attention in the role of occurrence and development of tumors and other chronic diseases, and the effect of iron-based magnetic nanoparticles on ferroptosis in tumor treatment applications remains to be elucidated. This review systematically introduces the development, types and preparation methods of iron-based magnetic nanometer drug-loading platforms, and detailedly summarizes the application of iron-based magnetic nanoparticles in the integration of tumor diagnosis and treatment, including magnetic field-assisted targeting, magnetic resonance imaging, and magnetocaloric therapy , and the mechanism of ferroptosis caused by the Fenton reaction is also iilustrated.

Key words: nano-drug delivery, iron-based magnetic nanocarriers, tumor, ferroptosis

中图分类号:

R730.5

牛盼红, 王岩, 刘营营, 张洁, 张书平, 刘思金. 铁基磁性纳米载体在肿瘤治疗中的应用[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(5): 333-339.

Niu Panhong, Wang Yan, Liu Yingying, Zhang Jie, Zhang Shuping, Liu Sijin. Application of iron-based magnetic nanocarriers in tumor therapy[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(5): 333-339.

参考文献

[1] Kang JH, Krause S, Tobin H, et al. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells[J]. Lab on a Chip, 2012,12:2175.
[2] Saadat M, Manshadi MKD, Mohammadi M, et al. Magnetic particle targeting for diagnosis and therapy of lung cancers[J]. Journal of Controlled Release: Official Journal of the Controlled Release Society,2020,328:776.
[3] Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer[J]. The Lancet Oncology, 2002,3:487.
[4] Ren X, Chen H, Yang V, et al. Iron oxide nanoparticle-based theranostics for cancer imaging and therapy[J]. Frontiers of Chemical Science and Engineering, 2014,8:253.
[5] Zhao S, Yu X, Qian Y, et al. Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics[J]. Theranostics, 2020,10:6278.
[6] Shan X, Li S, Sun B, et al. Ferroptosis-driven nanotherapeutics for cancer treatment[J]. Journal of Controlled Release: Official Journal of the Controlled Release Society,2020,319:322.
[7] Qiu Y, Cao Y, Cao W, et al. The application of ferroptosis in diseases[J]. Pharmacological Research, 2020,159:104919.
[8] Krukemeyer MGKV, Huebner F, Wagner W, et al. History and possible uses of nanomedicine based on nanoparticles and nanotechnological progress[J]. Journal of Nanomedicine and Nanotechnology, 2015,6:1000336.
[9] Zhou J, Xue C, Hou Y, et al. Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors[J]. Biomaterials, 2019,197:129.
[10] Cai AY, Zhu YJ, Qi C. Biodegradable inorganic nanostructured biomaterials for drug delivery[J]. Advanced Materials Interfaces, 2020,7:2000819.
[11] Bertran O, Revilla-Lopez G, Casanovas J, et al. Dissolving hydroxyolite: A DNA molecule into its hydroxyapatite mold[J]. Chemistry-A European Journal, 2016,22:6631.
[12] Wang L, Nancollas GH. Calcium orthophosphates: crystallization and dissolution[J]. Chemical Reviews,2008,108:4628.
[13] Qi C, Huang JJ, Chen F, et al. Synthesis, characterization and applications of calcium carbonate/fructose 1,6-bisphosphate composite nanospheres and carbonated hydroxyapatite porous nanospheres[J]. Journal of Materials Chemistry B,2014,2:8378.
[14] Qi C, Zhu YJ, Lu BQ, et al. ATP-stabilized amorphous calcium carbonate nanospheres and their application in protein adsorption[J]. Small, 2014,10:2047.
[15] Wei J, Cheang T, Tang B, et al. The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA[J]. Biomaterials,2013,34:1246.
[16] He XY, Liu BY, Xu C, et al. A multi-functional macrophage and tumor targeting gene delivery system for the regulation of macrophage polarity and reversal of cancer immunoresistance[J]. Nanoscale, 2018,10:15578.
[17] Abasian P, Ghanavati S, Rahebi S, et al. Polymeric nanocarriers in targeted drug delivery systems: A review[J]. Polymers for Advanced Technologies,2020,31:2939.
[18] Dehghani A, Bahlakeh G, Ramezanzadeh B. Synthesis of a non-hazardous/smart anti-corrosion nano-carrier based on beta-cyclodextrin-zinc acetylacetonate inclusion complex decorated graphene oxide (beta-CD-ZnA-MGO) [J]. Journal of Hazardous Materials,2020,398:122962.
[19] Deng ZY, Liu SY. Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles[J]. Journal of Controlled Release,2020,326:276.
[20] Chu BY, Qu Y, He XL, et al. ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy[J]. Adv Sci (Weinh), 2020,7(20):2001853.
[21] Li MQ, Zhao GK, Su WK, et al. Enzyme-responsive nanoparticles for anti-tumor drug delivery[J]. Front Chem,2020,8:647.
[22] Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects[J]. Advanced Drug Delivery Reviews, 2011,63:161.
[23] Au JLS, Yeung BZ, Wientjes MG, et al. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities[J]. Adv Drug Deliv Rev,2016,97:280.
[24] Guo XM, Li W, Luo LH, et al. External magnetic field-enchanced chemo-phoyothermal combination tumor therapy via iron oxide nanoparticles[J]. ACS Appl Mater Interfaces, 2017,9(19):16581.
[25] Kostevsek N, Cheung CCL, Sersa I, et al. Magneto-liposomes as MRI contrast agents: A systematic study of different liposomal formulations[J]. Nanomaterials (Basel), 2020,10(5):889.
[26] Song Q, Zhang Z. Shape control and associated magnetic properties of spinel cobalt ferrite nanocrystals[J]. J Am Chem Soc, 2004,126:6164.
[27] Hycen T, Lee S, Park J, et al. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process[J]. J Am Chem Soc, 2001,123:12798.
[28] Li Z, Sun Q, Gao M. Preparation of water-soluble magnetite nanocrystals from hydrated ferric salts in 2-pyrrolidone: Mechanism leading to Fe₃O₄[J]. Angew Chem Int Ed, 2005,44:123.
[29] Woo K, Lee HJ, Ahn J, et al. Sol-gel mediated synthesis of Fe₂O₃ nanorods[J]. Adv Mater, 2003,15:1761.
[30] Sun S, Zeng H, Robinson DB, et al. Monodisperse MFe₂O₄ (M=Fe, Co, Mn) nanoparticles[J]. Journal of the American Chemical Society, 2004,126:273.
[31] Sugimoto T, Itoh H, Mochida T. Shape control of monodisperse hematite particles by organic additives in the gel-sol system[J]. J Colloid Interface Sci, 1998,205(1):42.
[32] Han LH, Liu H, Wei Y. In situ synthesis of hematite nanoparticles using a low-temperature microemulsion method[J]. Powder Technology, 2011,207:42.
[33] Lian JB, Duan XC, Ma JM. Hematite (α-Fe₂O₃) with various morphologies: ionic liquid-assisted synthesis, formation mechanism, and properties[J]. ACS Nano, 2009,3:3749.
[34] Sharma R, Thakur P, Sharma P, et al. Ferrimagnetic Ni²⁺ doped Mg-Zn spinel ferrite nanoparticles for high density information storage[J]. Journal of Alloys and Compounds, 2017,704: 7.
[35] Zhang L, Liu Z, Liu Y, et al. Ultrathin surface coated water-soluble cobalt ferrite nanoparticles with high magnetic heating efficiency and rapid in vivo clearance[J]. Biomaterials, 2020,230:119655.
[36] Haribabu V, Sharmiladevi P, Akhtar N, et al. Label free ultrasmall fluoromagnetic ferrite-clusters for targeted cancer imaging and drug delivery[J]. Curr Drug Deliv, 2019,16(3):233.
[37] Liu X, Qi X, Zhang L. 3D hierarchical magnetic hollow sphere-like CuFe₂O₄ combined with HPLC for the simultaneous determination of Sudan I-IV dyes in preserved bean curd[J]. Food Chemistry, 2018,241:268.
[38] Sang M, Luo R, Bai Y, et al. BHQ-cyanine-based "off-on" long-circulating assembly as a ferroptosis amplifier for cancer treatment: A lipid-peroxidation burst device[J]. ACS Applied Materials & Interfaces, 2019,11:42873.
[39] Flanagan SW, Moseley PL, Buettner GR. Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping[J]. FEBS Lett, 1998,431:285.
[40] Ludwig RTF, Teichgraeber U, Hilger I. Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer[J]. Int J Nanomedicine, 2017, 12:1009.
[41] Wang SH, Luo J, Zhang ZH, et al. Iron and magnetic: new research direction of the ferroptosis-based cancer therapy[J]. American Journal of Cancer Research, 2018,8:1933.
[42] Yue L, Wang J, Dai Z, et al. pH-responsive, self-sacrificial nanotheranostic agent for potential in vivo and in vitro dual modal MRI/CT imaging, real-time, and in situ monitoring of cancer therapy[J]. Bioconjugate Chemistry, 2017,28:400.
[43] Liu YM, Yang K, Cheng L, et al. PEGylated FePt@Fe₂O₃ core-shell magnetic nanoparticles: Potential theranostic applications and in vivo toxicity studies[J]. Nanomedicine-Nanotechnology Biology and Medicine, 2013,9:1077.
[44] Chou SW, Shau YH, Wu PC, et al. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging[J]. Journal of the American Chemical Society, 2010,132:13270.
[45] Chen S, Wang LJ, Duce SL, et al. Engineered biocompatible nanoparticles for in vivo imaging applications[J]. Journal of the American Chemical Society, 2010,132:15022.
[46] Gilchrist RK, Medal R, Shorey WD, et al. Selective inductive heating of lymph nodes[J]. Annals of Surgery, 1957, 146(4):596.
[47] Kobayashi T, Kida Y, Tanaka T, et al. Interstitial hyperthermia of malignant brain tumors by implant heating system: Clinical experience[J]. J Neuro Oncol, 1991,10:153.
[48] Deger S, Boehmer D, Türk I, et al. Interstitial hyperthermia using self-regulating thermoseeds combined with conformal radiation therapy[J]. Eur Urol, 2002,42:147.
[49] Akiyama SKS, Kodera Y. A new method of thermo-chemotherapy using a stent for patients with esophageal cancer[J]. Surg Today, 2006, 36(1): 19.
[50] Johannsen MGU, Taymoorian K. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial[J]. Int J Hyperthermia, 2007,23:315.
[51] Wust P, Hildebrandt B, Sreenivasa G,et al. Hyperthermia in combined treatment of cancer[J]. Lancet Oncol, 2002,3:487.
[52] Xiang Z, Qi Y, Lu Y, et al. MOF-derived novel porous Fe₃O₄@C nanocomposites as smart nanomedical platforms for combined cancer therapy: magnetic-triggered synergistic hyperthermia and chemotherapy[J]. Journal of Materials Chemistry B, 2020,8:8671.
[53] Wang C, Zhao N, Huang Y, et al. Coordination of injectable self-healing hydrogel with Mn-Zn ferrite@mesoporous silica nanospheres for tumor MR imaging and efficient synergistic magnetothermal-chemo-chemodynamic therapy[J]. Chemical Engineering Journal, 2020,401:126100.
[54] Du ZZ, Sun Y, Liu J, et al. Design of a temperature measurement and feedback control system based on an improved magnetic nanoparticle thermometer[J]. Measurement Science and Technology, 2018,29(4):5003.
[55] Zhang W, Zuo XD, Niu Y, et al. Novel nanoparticles with Cr³⁺substituted ferrite for self-regulating temperature hyperthermia[J]. Nanoscale, 2017,9:13929.
[56] McNerny KL, Kim Y, Laughlin DE, et al. Chemical synthesis of monodisperse gamma-Fe-Ni magnetic nanoparticles with tunable curie temperatures for self-regulated hyperthermia[J]. Journal of Applied Physics, 2010,7(9pt.2):S2951.
[57] Yao AH, Ai FR, Wang DP, et al. Synthesis, characterization and in vitro cytotoxicity of self-regulating magnetic implant material for hyperthermia application[J]. Materials Science & Engineering C-Materials for Biological Applications, 2009,29:2525.
[58] Li WP, Su CH, Chang YC, et al. Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome[J]. ACS Nano, 2016,10:2017.
[59] Huo MF, Wang LY, Chen Y, et al. Tumor-selective catalytic nanomedicine by nanocatalyst delivery[J]. Nat Commun,2017,8(1):357.
[60] Shen ZY, Liu T, Li Y, et al. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors[J]. ACS Nano, 2018,12:11355.

铁基磁性纳米载体在肿瘤治疗中的应用

Application of iron-based magnetic nanocarriers in tumor therapy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

[1]	毕泗允. 对比分析经胸腔镜微创外科与传统手术治疗原发性纵隔肿瘤的临床效果[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(6): 448-450.
[2]	刘成新, 李宝生. 免疫时代肿瘤放疗值得关注的研究方向[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(5): 327-332.
[3]	陈蕊, 张俊勇, 赵琪. 炎症标志物与消化系统恶性肿瘤相关性的研究进展[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(4): 317-320.
[4]	翟晓茜, 吴开祥, 张树鹏. Xp11.2易位/TFE3基因融合相关性肾癌3例临床病理学分析[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(3): 217-220.
[5]	王焕云, 袁金燕, 李希红. 无痛技术在肿瘤患儿应用超声引导下改良塞丁格PICC置管中的效果[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(2): 133-135.
[6]	陈民, 游美, 安明超. 肿瘤患者行PICC护理对治疗依从性和安全性的价值研究[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(2): 138-139.
[7]	王力, 孟庆民, 郭永新, 焦青. DSA图像肝脏肿瘤血管的提取与选择[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(1): 1-5.
[8]	李伟, 张良杰, 李冬冬, 赵守松. 奥沙利铂联合氟尿嘧啶/亚叶酸钙方案经肝动脉灌注化疗治疗晚期肝细胞癌[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(1): 37-40.